200 related articles for article (PubMed ID: 26910829)
1. Current Controversies in the Management of Myeloma Bone Disease.
Silbermann R; Roodman GD
J Cell Physiol; 2016 Nov; 231(11):2374-9. PubMed ID: 26910829
[TBL] [Abstract][Full Text] [Related]
2. [Multiple myeloma: progress in management aimed at improving QoL].
Abe M
Rinsho Ketsueki; 2016; 57(10):2104-2112. PubMed ID: 27795520
[TBL] [Abstract][Full Text] [Related]
3. Myeloma bone disease: pathogenesis, current treatments and future targets.
Walker RE; Lawson MA; Buckle CH; Snowden JA; Chantry AD
Br Med Bull; 2014 Sep; 111(1):117-38. PubMed ID: 25190762
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic role of bisphosphonate and radiation combination in the management of myeloma bone disease.
Ural AU; Avcu F
Clin Cancer Res; 2007 Jun; 13(11):3432. PubMed ID: 17545554
[No Abstract] [Full Text] [Related]
5. Biology and treatment of myeloma related bone disease.
Terpos E; Christoulas D; Gavriatopoulou M
Metabolism; 2018 Mar; 80():80-90. PubMed ID: 29175022
[TBL] [Abstract][Full Text] [Related]
6. An Evidence-Based Approach to Myeloma Bone Disease.
Bingham N; Reale A; Spencer A
Curr Hematol Malig Rep; 2017 Apr; 12(2):109-118. PubMed ID: 28243849
[TBL] [Abstract][Full Text] [Related]
7. Myeloma bone disease.
Berenson JR
Best Pract Res Clin Haematol; 2005; 18(4):653-72. PubMed ID: 16026743
[TBL] [Abstract][Full Text] [Related]
8. Treatment for myeloma bone disease.
Yeh HS; Berenson JR
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6279s-6284s. PubMed ID: 17062714
[TBL] [Abstract][Full Text] [Related]
9. The role of markers of bone remodeling in multiple myeloma.
Terpos E; Politou M; Rahemtulla A
Blood Rev; 2005 May; 19(3):125-42. PubMed ID: 15748961
[TBL] [Abstract][Full Text] [Related]
10. Emerging treatment approaches for myeloma-related bone disease.
Gavriatopoulou M; Dimopoulos MA; Kastritis E; Terpos E
Expert Rev Hematol; 2017 Mar; 10(3):217-228. PubMed ID: 28092987
[TBL] [Abstract][Full Text] [Related]
11. Myeloma bone disease and treatment options.
Yeh HS; Berenson JR
Eur J Cancer; 2006 Jul; 42(11):1554-63. PubMed ID: 16797971
[TBL] [Abstract][Full Text] [Related]
12. Myeloma bone disease.
Sanderson RD; Epstein J
J Bone Miner Res; 2009 Nov; 24(11):1783-8. PubMed ID: 19839769
[No Abstract] [Full Text] [Related]
13. Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy.
Kleber M; Udi J; Metzke B; Terpos E; Roodmann GD; Morgan G; Dispenzieri A; Einsele H; Wäsch R; Engelhardt M
Leuk Lymphoma; 2012 Jun; 53(6):1057-61. PubMed ID: 22149167
[TBL] [Abstract][Full Text] [Related]
14. [Mechanisms of osteogenic inhibition in myeloma bone disease and its targeted therapy].
Zhao SJ; Fu R; Shao ZH
Zhonghua Xue Ye Xue Za Zhi; 2013 Nov; 34(11):984-7. PubMed ID: 24294860
[No Abstract] [Full Text] [Related]
15. [Management of bone lesions in multiple myeloma].
Hata H; Mitsuya H
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1072-6. PubMed ID: 16912524
[TBL] [Abstract][Full Text] [Related]
16. Advances in the biology and treatment of bone disease in multiple myeloma.
Raje N; Roodman GD
Clin Cancer Res; 2011 Mar; 17(6):1278-86. PubMed ID: 21411443
[TBL] [Abstract][Full Text] [Related]
17. Bone disease in multiple myeloma.
Drake MT
Oncology (Williston Park); 2009 Dec; 23(14 Suppl 5):28-32. PubMed ID: 20128326
[TBL] [Abstract][Full Text] [Related]
18. [Multiple Myeloma - Current Status in Diagnostic Testing and Therapy].
Kehrer M; Koob S; Strauss A; Wirtz DC; Schmolders J
Z Orthop Unfall; 2017 Oct; 155(5):575-586. PubMed ID: 28806822
[No Abstract] [Full Text] [Related]
19. Management of multiple myeloma bone disease: impact of treatment on renal function.
Kanellias N; Gavriatopoulou M; Terpos E; Dimopoulos MA
Expert Rev Hematol; 2018 Nov; 11(11):881-888. PubMed ID: 30285492
[TBL] [Abstract][Full Text] [Related]
20. Myeloma bone disease: pathogenesis and treatment.
O'Donnell EK; Raje NS
Clin Adv Hematol Oncol; 2017 Apr; 15(4):285-295. PubMed ID: 28591104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
